LeonaBio (LONA) Stock Price

LeonaBio Price

NASDAQ·CLOSED
4.77
​
Market closed

Analysts set a median price target of 10.20 USD, implying 113.8% above the current price. Of 7 analysts, 0 rate the stock a buy — an overall Sell consensus.

LeonaBio stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

LeonaBio business model & stock analysis

Athira Pharma, Inc. is a clinical-stage biopharmaceutical company headquartered in Bothell, Washington, that generates revenue by developing small molecules to restore neuronal health and stop neurodegeneration. The firm utilizes its proprietary ATH platform to target and enhance the activity of a vital neuronal growth factor, creating a pipeline of drugs designed to cross the blood brain barrier for the central nervous system or target the peripheral nervous system. This technology underpins the development of ATH-1017, which is specifically intended for the treatment of neurodegenerative disorders with an initial focus on Alzheimer’s disease. The product aims to improve symptoms in cognitively impaired subjects by enhancing neuronal health and promoting regeneration, serving the medical needs of patients suffering from these conditions.

Frequently asked questions about LeonaBio

Analysts currently set an average price target of 10.20 USD for the LeonaBio stock (median: 10.20 USD), implying +113.8 % versus the latest price. The consensus is based on 7 analyst ratings.

10 analysts currently rate the LeonaBio stock: 9 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the LeonaBio share trades at 4.24 EUR (4.77 USD).

The LeonaBio share (LONA) is listed on 1 stock exchanges, including: NASDAQ (ATHA).

The revenue cannot currently be calculated for LeonaBio.

The profit cannot currently be calculated for LeonaBio.

The P/E ratio cannot be calculated for LeonaBio at the moment.

The P/S cannot be calculated for LeonaBio currently.

The Eulerpool Quality Score for LeonaBio is 2/10.

The ISIN of LeonaBio is US04746L2034. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of LeonaBio is A2QCFW. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of LeonaBio is LONA. The ticker symbol is used to trade LeonaBio shares on the stock exchange.

Fair ValueTerminal
4.72 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website athira.com
Currency
USD
Initial public offering
Sep 18, 2020
ISIN
US04746L2034
Cusip
04746L104
Sedol
BMTVQR6
Market capitalization
44.55 M USDMicro Cap
52-Week Range
PEG
0.01
P/E ratio
P/Ee 2028
-1.24
P/Ee 2029
-1.21
P/Ee 2030
-2.51
P/Ee 2031
—
P/S
P/Se
2.47
EV/EBIT
0.23
P/B Ratio
1.60
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-369.35 %
Last updated Nov 5, 2026, 3:37 AM

LeonaBio Peer Group

LeonaBio Ticker

NASDAQ · ATHA

All fundamentals and in-depth analysis of LeonaBio

Our stock analysis for LeonaBio stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of LeonaBio. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.